Which hedge funds own STOK? STOKE THERAPEUTICS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
5 of the hedge funds tracked by WhaleCreep disclosed a position in STOK (STOKE THERAPEUTICS INC) in their Q2 2026 13F filings, worth $42.0m in total. The largest holder by portfolio weight is Baillie Gifford at 0.0% of its book. 1 exited: Farallon Capital Management.
5tracked managers holding
0opened this quarter
1exited this quarter
Which hedge funds hold STOK? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Baillie Gifford | Q2 2026 | 0.0% | $13.9m | 517,275 | -10% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $16.0m | 489,301 | 298% | added |
| Millennium Management | Q2 2026 | 0.0% | $8.5m | 261,028 | -45% | reduced |
| Woodline Partners | Q2 2026 | 0.0% | $1.6m | 50,120 | 0% | held |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $1.9m | 57,847 | 16% | added |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Farallon Capital Management | 0.0% | $293.0k |
How has hedge fund ownership of STOK changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 5 | $42.0m |
| Q1 2026 | 6 | $39.3m |
| Q4 2025 | 5 | $49.3m |
| Q3 2025 | 2 | $32.9m |
| Q2 2025 | 1 | $1.1m |
| Q1 2025 | 2 | $1.8m |
| Q4 2024 | 3 | $2.7m |
| Q3 2024 | 1 | $1.2m |
| Q2 2024 | 3 | $1.8m |
| Q1 2024 | 4 | $4.1m |
| Q4 2023 | 1 | $299.3k |
| Q3 2023 | 2 | $296.1k |
| Q2 2023 | 3 | $1.7m |
| Q1 2023 | 4 | $1.6m |
| Q4 2022 | 3 | $1.4m |
| Q3 2022 | 4 | $13.3m |
Counts every tracked manager that disclosed STOK in that quarter's filing, including managers that have since stopped filing.